Ventures | Harvard Innovation Labs

Ventures

Browse a selection of current and former i-lab ventures.

Ventures

Lab

School

Program

Term

Industry

Clear all filters

Arcanist

Developing therapeutics for neurodegenerative diseases.
Bench Agent

Turning scattered lab notes and data into shared memory, knowledge, and insights with an AI lab agent to accelerate research.
Cellforma

Developing life-saving, first-of-its-kind regenerative cell therapies to overcome the unmet need for donor lungs.
Celsius Bio

A rapid diagnostic device providing antimicrobial susceptibility test results in hours, instead of days, to guide effective antibiotic treatments.
Concerto Biosciences

Discovering microbial ensembles for health via a patented screening platform.
Evergreen Saponins

Introducing Quillaja saponaria molina as a drought-friendly crop in California and harvesting its leaves to produce QS-21, a potent vaccine adjuvant.
GC Therapeutics

Using synthetic biology to program stem cells into any cell type with best-in-class efficiency, speed, and scalability.
ICOR

Improving codon optimization using deep neural networks — increasing the efficiency of recombinant expression.
Kinnos

Adding color to disinfectants, visualizing surface coverage for more effective and efficient cleaning in healthcare settings.
Lime Therapeutics

Creating a new class of therapies targeting lipid metabolism in cancers and neurodegenerative disorders.
Longevity Pioneering

Combating aging with Ageome, a multi-dimensional age clock, with GenAI and LLMs to create personalized aging report.
Lybra Bio

Developing innovative therapeutic platforms to treat Autoimmune skin diseases.
MabLab

Building five-in-one test strips to detect the five deadliest lacing agents in recreational drugs.
NanoDEX

Accelerating drug discovery by leveraging nanopore technology to target previously challenging proteins.
Overture Therapeutics

Creating better, healthier weight-loss intervention therapies for treating obesity and its co-morbidities by targeting emerging biological pathways.
PieD

Developing an AI-powered wearable photonic device for at-home heart failure monitoring through real-time, multi-biomarker detection.
Procure Bio

Engineering protein nanoparticles for targeted delivery of gene and protein therapeutics, advancing novel treatments for genetic diseases.
QMatter

Developing a new simulation technique that can predict the properties of molecular systems.
Radiate Biosciences

Redefining colorectal cancer screening with a blood test that delivers colonoscopy-level performance.
Revision Bio

Creating next-generation precision genome editing technologies.
Salience

Enabling high-bandwidth human–AI collaboration by allowing agents to understand user intent beyond text and command-based interactions.
Transcera

Transforming chronic disease treatment through improved biologic drug delivery.
Veri Nano

A bionanotechnology company developing antimicrobial materials and nanoparticle delivery systems for human and animal health.